We conducted a randomized controlled pilot trial to estimate surgical PPV of a `` 2 of 3 tests positive '' screening rule , and to compare use of HE4 as a first-line ( Arm 1 ) versus a second-line ( Arm 2 ) screen , in women at high and elevated risk for epithelial ovarian cancer ( EOC ) at five study sites .